A Study of Persistence to Guselkumab Treatment in Participants With Moderate-to-Severe Plaque Psoriasis in Romania

A Study of Guselkumab in Participants With Moderate to Severe Plaque-type Psoriasis and an Inadequate Response to Ustekinumab

NCT02203032 ·Status: COMPLETED ·Phase: PHASE3

Study of Guselkumab in Skin of Color Participants With Moderate-to-severe Plaque and/or Scalp Psoriasis

NCT05272150 ·Status: COMPLETED ·Phase: PHASE3

A Study of Guselkumab for the Treatment of Palmoplantar-non-Pustular Psoriasis

NCT03998683 ·Status: COMPLETED ·Phase: PHASE3

A Study of Guselkumab in Participants With Active Psoriatic Arthritis and an Inadequate Response to Anti-Tumor Necrosis Factor Alpha (Anti-TNF Alpha) Therapy

NCT03796858 ·Status: COMPLETED ·Phase: PHASE3

A Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis With Randomized Withdrawal and Retreatment

NCT02207244 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Comparative Efficacy of CNTO 1959 (Guselkumab) and Secukinumab for the Treatment of Moderate to Severe Plaque-type Psoriasis

NCT03090100 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis

NCT02905331 ·Status: COMPLETED ·Phase: PHASE3

A Study of Guselkumab Treatment Persistence in Psoriatic Arthritis Participants

NCT07532226 ·Status: RECRUITING

Effect of Guselkumab on Cardiovascular Risk Surrogate Markers in Participants With Moderate to Severe Plaque Psoriasis

NCT05125679 ·Status: TERMINATED ·Phase: PHASE4

An Explorative Psoriasis Biomarker Study

NCT04394936 ·Status: TERMINATED ·Phase: NA

Real-Life Evaluation of Guselkumab Dosing Interval Adjustments

NCT07430319 ·Status: RECRUITING

A Study of Guselkumab in Naive or Bio-experienced Participants With Regional (Facial and Genital) Psoriasis

NCT04439526 ·Status: COMPLETED

A Study of Guselkumab (TREMFYA) in Chinese Participants With Moderate to Severe Plaque Psoriasis

NCT04914429 ·Status: COMPLETED ·Phase: PHASE4

A Study to Evaluate Comparative Efficacy and Safety of Guselkumab in High-dose and Extended-interval Versus Standard-dose in Chinese Participants of Moderate-to-severe Plaque Psoriasis

NCT07532486 ·Status: RECRUITING ·Phase: NA

Comparison of Secukinumab Versus Guselkumab in Clearing Psoriatic Plaques Refractory to Ustekinumab

NCT03553823 ·Status: COMPLETED ·Phase: PHASE2

A Study of Guselkumab in Participants With Psoriatic Arthritis (PsA) in a Real-World Setting

NCT07220824 ·Status: RECRUITING

A Study of Guselkumab Administered Subcutaneously in Bio-naive Participants With Active Psoriatic Arthritis Axial Disease

NCT04929210 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4

Potential Role of Guselkumab in Modulating PAIN Perception and Related Gene Pathways: a Proof-of-concept Study.

NCT06974474 ·Status: RECRUITING ·Phase: PHASE4

Therapeutic Drug Monitoring of Guselkumab in Psoriasis Patients

NCT04080648 ·Status: COMPLETED ·Phase: PHASE4

Proactive TDM Versus Standard Use of Biologics in Psoriasis

NCT06398106 ·Status: RECRUITING ·Phase: PHASE4

Safety and Efficacy of Multiple Doses of BT061 in Patients With Moderate to Severe Chronic Plaque Psoriasis

NCT01072383 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Subcutaneously Administered Guselkumab for the Treatment of Chronic Plaque Psoriasis in Pediatric Participants

NCT03451851 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Efficacy and Safety of Brodalumab Compared With Guselkumab in the Treatment of Plaque Psoriasis After Inadequate Response to Ustekinumab

NCT04533737 ·Status: TERMINATED ·Phase: PHASE4

An Efficacy and Safety of CNTO 1959 (Guselkumab) in Participants With Moderate to Severe Plaque-type Psoriasis

NCT02325219 ·Status: COMPLETED ·Phase: PHASE3

Immune Spatial Features of Guselkumab Cutaneous Response

NCT05858632 ·Status: RECRUITING ·Phase: PHASE4